Countach Research Image S&P 500 excluding and including FAAANM

How an approved vaccine can crash the S&P 500

The stock market is underpricing the probability of an approved COVID-19 vaccine by November, according to Goldman Sachs strategists. Their strategists believe that an approved vaccine could lead to a market crash. Common sense calls for the opposite to be true, as a vaccine should be a boost for the economy. In fact, it actually …

How an approved vaccine can crash the S&P 500 Read More ยป